| Initial visit | Final visit | Single visit |
---|---|---|---|
 | (N=1568) | (N=1568) | (N=339) |
Age continuous mediana | 8.0 (5.0-14.0) | 7.0 (5.0-10.0) | |
Age stratifiedb | |||
 Children | 1181 (75.3%) | 316 (93.2%) | |
 Adults | 387 (24.7%) | 23 (6.8%) | |
Sex | |||
 Male | 756 (48.2%) | 184 (54.3%) | |
 Female | 812 (51.8%) | 155 (45.7%) | |
Dates collectionc | |||
 1st week | 465 (29.7%) | 0 (0.0%) | 59 (17.4%) |
 2nd week | 873 (55.7%) | 46 (2.9%) | 175 (51.3%) |
 3rd week | 216 (13.8%) | 385 (24.6%) | 73 (21.5%) |
 4th week | 14 (0.9%) | 603 (38.5%) | 25 (7.4%) |
 5th week | 0 (0.0%) | 535 (34.1%) | 8 (2.4%) |
SARS-CoV-2 RT-PCRd | |||
 Positive | 2 (0.1%) | 7 (0.4%) | 2 (0.6%) |
 Negative | 1552 (99.2%) | 1557 (99.5%) | 335 (98.8%) |
 Indeterminate | 1 (0.1%) | 1 (0.1%) | 0 (0.0%) |
 Not valid | 9 (0.6%) | 0 (0.0%) | 2 (0.6%) |
Symptoms | |||
 Yes | 71 (4.5%) | 76 (4.8%) | 16 (4.7%) |
  Children | 62 (5.2%) | 65 (5.5%) | 16 (5.1%) |
  Adults | 9 (2.3%) | 11 (2.8%) | 0 (0.0%) |
 No | 1492 (95.2%) | 1492 (95.2%) | 323 (95.3%) |
  Children | 1119 (94.8%) | 1116 (94.5%) | 300 (94.9%) |
  Adults | 378 (97.7%) | 376 (97.2%) | 23 (100%) |